ISAC Honorary Membership is conferred upon persons who have brought outstanding contributions to antimicrobial chemotherapy. is Prof. David Paterson.

Professor Paterson directs ADVANCE-ID (ADVANcing Clinical Evidence for Infectious Diseases) at Saw Swee Hock School of Public Health. ADVANCE-ID is a clinical trials network comprising more than 40 hospitals across Asia. This network is jointly funded by the Wellcome Trust and a number of Singaporean institutions with an aim to conduct clinically important trials in the field of antimicrobial resistance (AMR). This comprises trials of antibiotics, diagnostics and prevention strategies.. He is also an Honorary Professor at the University of Queensland and has more than 500 peer-reviewed publications predominantly in the area of AMR. His research focuses on the molecular and clinical epidemiology of infections with antibiotic-resistant organisms, with the intent of translating knowledge into optimal prevention and treatment of these infections. Multi-country clinical trials are the major component of his research portfolio, and the predominant focus of ADVANCE-ID.

Prof. Paterson presented his keynote lecture on "Averting the antimicrobial resistance crisis: barriers to effective antimicrobial stewardship" at the ICC in Istanbul. The recording will be available soon.

2024 Awardee

Previous Awardees